Preparing for genomic medicine: a real world demonstration of health system change

Organisations and governments seeking to implement genomics into clinical practice face numerous challenges across multiple, diverse aspects of the health care system. It is not sufficient to tackle any one aspect in isolation: to create a system that supports genomic medicine, they must be addressed simultaneously. The growing body of global knowledge can guide decision-making, but each jurisdiction or organisation needs a model for genomic (or personalised) medicine that is tailored to its unique context, its priorities and the funds available. Poor decisions could greatly reduce the benefits that could potentially arise from genomic medicine. Demonstration projects enable models to be tested, providing valuable evidence and experience for subsequent implementation. Here, we present the Melbourne Genomics Health Alliance demonstration project as an exemplar of a collaborative, holistic approach to phased implementation of genomics across multiple autonomous institutions. The approach and lessons learned may assist others in determining how best to integrate genomics into their healthcare system.

[1]  G. Ginsburg.  Realizing the opportunities of genomics in health care. , 2013, JAMA.

[2]  Xuan Yuan,et al.  Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders , 2014, Science Translational Medicine.

[3]  Robert West,et al.  The Behaviour Change Wheel: A Guide To Designing Interventions , 2014 .

[4]  S. Michie,et al.  The behaviour change wheel: A new method for characterising and designing behaviour change interventions , 2011, Implementation science : IS.

[5]  Clara Gaff,et al.  Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions , 2017, JAMA pediatrics.

[6]  datasets,et al.  From the Consumers Health Forum of Australia , 2013 .

[7]  Denis C. Bauer,et al.  Cpipe: a shared variant detection pipeline designed for diagnostic settings , 2015, bioRxiv.

[8]  G. Ginsburg,et al.  Medical genomics: Gather and use genetic data in health care , 2014, Nature.

[9]  Steve Olson,et al.  Applying an Implementation Science Approach to Genomic Medicine: Workshop Summary , 2016 .

[10]  Jacek Majewski,et al.  Next-generation sequencing for diagnosis of rare diseases in the neonatal intensive care unit , 2016, Canadian Medical Association Journal.

[11]  Denise L. Perry,et al.  Are physicians prepared for whole genome sequencing? a qualitative analysis , 2016, Clinical genetics.

[12]  Laurie D. Smith,et al.  Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. , 2015, The Lancet. Respiratory medicine.

[13]  J. Manyika,et al.  Disruptive technologies: Advances that will transform life, business, and the global economy , 2013 .

[14]  E. Clayton,et al.  Imagined Futures: Capturing the Benefits of Genome Sequencing for Society , 2013 .

[15]  Karim Benkirane,et al.  Comparison of DNA methylation profiles in human fetal and adult red blood cell progenitors , 2015, Genome Medicine.

[16]  Alison B. Hamilton,et al.  Factors influencing organizational adoption and implementation of clinical genetic services , 2013, Genetics in Medicine.

[17]  K. Boycott,et al.  Rare-disease genetics in the era of next-generation sequencing: discovery to translation , 2013, Nature Reviews Genetics.

[18]  M. Petticrew,et al.  Developing and evaluating complex interventions: the new Medical Research Council guidance , 2008, BMJ : British Medical Journal.

[19]  Clara Gaff,et al.  Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement , 2017, Genetics in Medicine.

[20]  Geoffrey M. Curran,et al.  Effectiveness-implementation Hybrid Designs: Combining Elements of Clinical Effectiveness and Implementation Research to Enhance Public Health Impact , 2012, Medical care.

[21]  Monique M. Ryan,et al.  Diagnostic and cost utility of whole exome sequencing in peripheral neuropathy , 2017, Annals of clinical and translational neurology.

[22]  Andrew Cole,et al.  Cancer expert doubts claims about prostate cancer trial , 2008, BMJ : British Medical Journal.

[23]  E. Suchman.  Evaluative Research: Principles and Practice in Public Service and Social Action Progr , 1968 .

[24]  Rachel G Liao,et al.  A federated ecosystem for sharing genomic, clinical data , 2016, Science.

[25]  K. Payne,et al.  Valuing the economic benefits of complex interventions: when maximising health is not sufficient. , 2013, Health economics.

[26]  Magalie S Leduc,et al.  Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.

[27]  Satoru Miyano,et al.  Global implementation of genomic medicine: We are not alone , 2015, Science Translational Medicine.

[28]  Alejandro Sifrim,et al.  Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data , 2015, The Lancet.

[29]  Clara Gaff,et al.  Patient safety in genomic medicine: an exploratory study , 2016, Genetics in Medicine.

[30]  Keith Marsolo,et al.  Practical considerations in genomic decision support: The eMERGE experience , 2015, Journal of pathology informatics.

[31]  H. Burton,et al.  A toolkit for incorporating genetics into mainstream medical services: Learning from service development pilots in England , 2010, BMC health services research.

[32]  Patricia J. Rogers,et al.  Purposeful Program Theory: Effective Use of Theories of Change and Logic Models , 2011 .

[33]  H. Dominic Covvey,et al.  Healthcare as a complex adaptive system , 2018 .

[34]  D. Ledbetter,et al.  Recommendations for the integration of genomics into clinical practice , 2016, Genetics in Medicine.

[35]  B. Fernandez,et al.  Utility of whole‐exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care , 2015, Clinical genetics.

[36]  Dan M. Roden,et al.  Implementing genomic medicine in the clinic: the future is here , 2013, Genetics in Medicine.

[37]  I. Scheffer,et al.  Real-world utility of whole exome sequencing with targeted gene analysis for focal epilepsy , 2017, Epilepsy Research.